G. Höffken

4.7k total citations
97 papers, 2.8k citations indexed

About

G. Höffken is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, G. Höffken has authored 97 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Epidemiology, 42 papers in Pulmonary and Respiratory Medicine and 25 papers in Pharmacology. Recurrent topics in G. Höffken's work include Pneumonia and Respiratory Infections (27 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). G. Höffken is often cited by papers focused on Pneumonia and Respiratory Infections (27 papers), Antibiotics Pharmacokinetics and Efficacy (21 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (12 papers). G. Höffken collaborates with scholars based in Germany, United States and Austria. G. Höffken's co-authors include P. Koeppe, K. Börner, H. Lode, Michael S. Niederman, Martin Kolditz, Ralf Ewert, Christian Opitz, Roland Wensel, Roland Hetzer and Jörg Winkler and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

G. Höffken

90 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Höffken Germany 29 1.1k 1.0k 690 525 328 97 2.8k
Petros Kopterides Greece 30 976 0.9× 462 0.5× 280 0.4× 499 1.0× 489 1.5× 93 2.9k
Álvaro Réa-Neto Brazil 16 1.2k 1.1× 469 0.5× 285 0.4× 226 0.4× 457 1.4× 47 2.2k
Nobuaki Shime Japan 29 778 0.7× 975 1.0× 277 0.4× 246 0.5× 404 1.2× 233 2.9k
Soumitra R. Eachempati United States 33 1.2k 1.1× 885 0.9× 408 0.6× 414 0.8× 273 0.8× 98 4.5k
Heinz Burgmann Austria 34 1.5k 1.4× 559 0.5× 618 0.9× 141 0.3× 319 1.0× 202 4.0k
Ronald F. Grossman Canada 33 2.1k 1.9× 2.0k 1.9× 414 0.6× 158 0.3× 320 1.0× 77 4.7k
Benoît Veber France 25 1.6k 1.5× 632 0.6× 352 0.5× 179 0.3× 199 0.6× 125 3.2k
Guy A. Richards South Africa 32 804 0.7× 619 0.6× 255 0.4× 103 0.2× 447 1.4× 163 3.2k
Fabrice Zéni France 33 1.4k 1.3× 639 0.6× 171 0.2× 263 0.5× 122 0.4× 76 3.3k
Fabienne Fieux France 18 1.2k 1.1× 471 0.5× 214 0.3× 160 0.3× 222 0.7× 40 2.4k

Countries citing papers authored by G. Höffken

Since Specialization
Citations

This map shows the geographic impact of G. Höffken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Höffken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Höffken more than expected).

Fields of papers citing papers by G. Höffken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Höffken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Höffken. The network helps show where G. Höffken may publish in the future.

Co-authorship network of co-authors of G. Höffken

This figure shows the co-authorship network connecting the top 25 collaborators of G. Höffken. A scholar is included among the top collaborators of G. Höffken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Höffken. G. Höffken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kolditz, Martin, et al.. (2016). Burden and risk factors of ambulatory or hospitalized CAP: A population based cohort study. Respiratory Medicine. 121. 32–38. 52 indexed citations
3.
Bütof, Rebecca, K A Kirchner, Steffen Appold, et al.. (2014). Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer. Strahlentherapie und Onkologie. 190(3). 263–269. 12 indexed citations
4.
Kolditz, Martin, G. Höffken, Peter Martus, et al.. (2012). Serum cortisol predicts death and critical disease independently of CRB-65 score in community-acquired pneumonia: a prospective observational cohort study. BMC Infectious Diseases. 12(1). 90–90. 42 indexed citations
5.
Kolditz, Martin, Michael Halank, B. Schulte‐Hubbert, et al.. (2012). Copeptin predicts clinical deterioration and persistent instability in community-acquired pneumonia. Respiratory Medicine. 106(9). 1320–1328. 45 indexed citations
7.
Wiedemann, B., et al.. (2011). Forceps biopsy and suction catheter for sampling in pulmonary nodules and infiltrates. European Respiratory Journal. 39(6). 1432–1436. 7 indexed citations
8.
Koschel, Dirk, et al.. (2009). Hypersensitivity pneumonitis associated with the use of temozolomide. European Respiratory Journal. 33(4). 931–934. 9 indexed citations
10.
Allewelt, M., et al.. (2008). Wandel im Erregerspektrum ambulant erworbener Pneumonien (1982-1992). DMW - Deutsche Medizinische Wochenschrift. 122(34/35). 1027–1032. 1 indexed citations
12.
Gillissen, Adrian, G. Höffken, & Uwe R. Juergens. (2005). Gemeinsamkeiten der allergischen Rhinitis und des allergischen Asthma bronchiale?Die „One-Airway-One-Disease”-Hypothese. Pneumologie. 59(3). 192–200. 4 indexed citations
13.
Höffken, G., J. Lorenz, Wolfgang Kern, et al.. (2005). S3-guideline on Ambulant Acquired Pneumonia and Deep Airway Infections. Pneumologie. 59(9). e1–e63. 27 indexed citations
14.
Kolditz, Martin, Michael Halank, Petra Spornraft‐Ragaller, Herbert Schmidt, & G. Höffken. (2005). Localized Pulmonary Infection Associated with Mycobacterium tilburgii in an HIV–Infected Patient. Infection. 33(4). 278–281. 12 indexed citations
15.
Halank, Michael, Christian Marx, Gustavo Baretton, et al.. (2004). Severe Pulmonary Hypertension in Chronic Idiopathic Myelofibrosis. Oncology Research and Treatment. 27(5). 472–474. 7 indexed citations
16.
Dalhoff, Klaus, Santiago Ewig, G. Höffken, et al.. (2002). Empfehlungen zur Diagnostik, Therapie und Prävention von Pneumonien bei erworbenem Immundefizit. Pneumologie. 56(12). 807–831. 7 indexed citations
17.
Steinhoff, D., H. Lode, G. Ruckdeschel, et al.. (1996). Chlamydia pneumoniae as a Cause of Community-Acquired Pneumonia in Hospitalized Patients in Berlin. Clinical Infectious Diseases. 22(6). 958–964. 63 indexed citations
18.
Höffken, G.. (1993). Clinical Requirements in the Treatment of Today’s Respiratory Tract Infections. Respiration. 60(1). 3–9. 3 indexed citations
19.
Höffken, G., et al.. (1992). Application of the polymerase chain reaction in the diagnosis of pulmonary toxoplasmosis in immunocompromised patients. European Journal of Clinical Microbiology & Infectious Diseases. 11(12). 1177–1181. 35 indexed citations
20.
Lode, H., G. Höffken, K. Börner, & P. Koeppe. (1989). Unique Aspects of Quinolone Pharmacokinetics. Clinical Pharmacokinetics. 16(Supplement 1). 1–4. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026